TRMT6 and central nervous system cancer: Moreover, a concomitant increase in TRMT6/TRMT61 mRNA and tRNAi (Met) expression with decreased expression of PKCα mRNA was detected in highly aggressive glioblastoma as compared with Grade 2/3 glioma (111).